Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.
作者信息
Zucman Noémie, Uhel Fabrice, Descamps Diane, Roux Damien, Ricard Jean-Damien
机构信息
AP-HP, Hôpital Louis Mourier, Médecine Intensive Réanimation, DMU ESPRIT, Colombes, France.
Université de Paris, UFR de médecine Paris Nord, Paris, France.
出版信息
Clin Infect Dis. 2021 Nov 16;73(10):1945-1946. doi: 10.1093/cid/ciab129.
Abstract
摘要
相似文献
1
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.南非严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体501Y.V2的严重再感染
Clin Infect Dis. 2021 Nov 16;73(10):1945-1946. doi: 10.1093/cid/ciab129.
2
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.南非新冠病毒 501Y.V2 变异株可逃避南非捐赠者血浆的中和作用。
Nat Med. 2021 Apr;27(4):622-625. doi: 10.1038/s41591-021-01285-x. Epub 2021 Mar 2.
3
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.严重急性呼吸综合征冠状病毒 2 变种 501Y.V2 和 501Y.V1 的敏感免疫检测
J Infect Dis. 2021 Aug 16;224(4):616-619. doi: 10.1093/infdis/jiab278.
4
Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant.关于501Y.V2变体导致的严重SARS-CoV-2感染的初步数据。
Anaesth Crit Care Pain Med. 2021 Aug;40(4):100890. doi: 10.1016/j.accpm.2021.100890. Epub 2021 May 24.
5
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.密歇根家庭流感疫苗评估（HIVE）队列中冠状病毒的发生：再感染频率和对季节性和严重急性呼吸综合征冠状病毒的血清学反应。
J Infect Dis. 2021 Jul 2;224(1):49-59. doi: 10.1093/infdis/jiab161.
6
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.在新诊断的COVID-19患者的鼻咽样本中，501Y.V2新冠病毒变体的病毒载量介于501Y.V1变体和历史变体之间。
J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.04.023. Epub 2021 Apr 28.
7
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.基因组证据表明巴西出现涉及 Spike 蛋白 E484K 突变的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
8
Prognosis of patients with acute respiratory failure due to the SARS-CoV-2 501Y.V2 variant: a multicenter retrospective matched cohort study.SARS-CoV-2 501Y.V2 变异株导致急性呼吸衰竭患者的预后：一项多中心回顾性匹配队列研究。
Sci Rep. 2022 May 24;12(1):8747. doi: 10.1038/s41598-022-12767-4.
9
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.南非严重急性呼吸综合征冠状病毒2变种501Y.V2传入英国。
J Infect. 2021 Apr;82(4):e8-e10. doi: 10.1016/j.jinf.2021.01.007. Epub 2021 Jan 17.
10
Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant.采用缺失策略开发多重逆转录定量聚合酶链反应以筛查严重急性呼吸综合征冠状病毒2（SARS-CoV-2）南非501Y.V2变体。
J Infect. 2021 Jul;83(1):e19-e21. doi: 10.1016/j.jinf.2021.04.035. Epub 2021 May 3.
引用本文的文献
1
The unseen pandemic: treatment delays and loss to follow-up due to fear of COVID.隐匿的大流行：因恐惧新冠而导致的治疗延误和失访
J Anesth Analg Crit Care. 2022 Jan 28;2(1):5. doi: 10.1186/s44158-021-00032-5.
2
Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients.癌症与 COVID-19：探讨免疫相互作用，并回顾针对癌症患者严重 SARS-CoV-2 的有前途治疗方法。
J Hematol Oncol. 2023 Apr 13;16(1):39. doi: 10.1186/s13045-023-01432-6.
3
An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants.病毒突变及其对 SARS-CoV-2 变异株发病机制影响概述。
Front Immunol. 2022 Nov 28;13:1034444. doi: 10.3389/fimmu.2022.1034444. eCollection 2022.
4
Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site.一种再现SARS-CoV-2 S RBD/ACE2结合位点的简化模型的结构分析
Heliyon. 2022 Nov 15;8(11):e11568. doi: 10.1016/j.heliyon.2022.e11568. eCollection 2022 Nov.
5
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.SARS-CoV-2 再感染在保加利亚前三次 COVID-19 大流行期间。
PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022.
6
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.新冠病毒二次感染患者的临床和流行病学特征：一项系统综述
New Microbes New Infect. 2022 Jul;48:101021. doi: 10.1016/j.nmni.2022.101021. Epub 2022 Aug 28.
7
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.自然免疫对 SARS-CoV-2 的作用，以及接种疫苗和未接种疫苗的癌症患者突破性感染的情况。
Br J Cancer. 2022 Nov;127(10):1787-1792. doi: 10.1038/s41416-022-01952-x. Epub 2022 Aug 22.
8
Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far.严重急性呼吸综合征冠状病毒、中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2感染的经验教训：我们目前所了解的情况。
Can J Infect Dis Med Microbiol. 2022 Aug 12;2022:1156273. doi: 10.1155/2022/1156273. eCollection 2022.
9
Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru.秘鲁利马和卡亚俄在以拉姆达毒株为主的第二波疫情后出现的严重急性呼吸综合征冠状病毒2确诊再感染病例。
Open Forum Infect Dis. 2022 Mar 16;9(6):ofac134. doi: 10.1093/ofid/ofac134. eCollection 2022 Jun.
10
Prognosis of patients with acute respiratory failure due to the SARS-CoV-2 501Y.V2 variant: a multicenter retrospective matched cohort study.SARS-CoV-2 501Y.V2 变异株导致急性呼吸衰竭患者的预后：一项多中心回顾性匹配队列研究。
Sci Rep. 2022 May 24;12(1):8747. doi: 10.1038/s41598-022-12767-4.
Zotero 插件